Gotu Kola (Centella asiatica) contains triterpenoid saponins (asiaticoside, madecassoside, asiatic acid, and madecassic acid) that enhance cognitive function by increasing BDNF levels and protecting neurons from oxidative damage, while also promoting wound healing and vascular health through stimulating collagen synthesis and reducing inflammation, with clinical evidence supporting its benefits for memory, attention, and venous insufficiency at 300-600mg daily of standardized extract (40% triterpenes), though it should be avoided during pregnancy and by those with liver disease.
Alternative Names: Centella asiatica, Indian Pennywort, Brahmi, Mandookaparni, Asiatic Pennywort, Tiger Herb, Hydrocotyle asiatica
Categories: Adaptogen, Nootropic, Medicinal Herb, Ayurvedic Herb
Primary Longevity Benefits
- Cognitive enhancement
- Neuroprotection
- Wound healing
- Vascular health
Secondary Benefits
- Anxiety reduction
- Stress management
- Skin health
- Anti-inflammatory
- Antioxidant support
- Collagen production
Mechanism of Action
Gotu Kola (Centella asiatica) exerts its diverse therapeutic effects through multiple mechanisms, primarily attributed to its bioactive compounds, especially the triterpenoid saponins (asiaticoside, madecassoside, asiatic acid, and madecassic acid) and other constituents including flavonoids, phytosterols, and phenolic compounds. In the central nervous system, Gotu Kola demonstrates neuroprotective properties by modulating several pathways. It enhances antioxidant defense mechanisms by increasing the activities of superoxide dismutase (SOD), catalase, and glutathione peroxidase, thereby reducing oxidative stress and preventing neuronal damage. Research indicates that Gotu Kola’s triterpenoids can cross the blood-brain barrier and protect neurons from beta-amyloid toxicity, a key factor in Alzheimer’s disease pathology.
Additionally, it promotes neurogenesis and synaptogenesis by increasing brain-derived neurotrophic factor (BDNF) levels, which supports the growth and differentiation of neurons and enhances synaptic plasticity. Gotu Kola also modulates neurotransmitter systems, particularly by influencing gamma-aminobutyric acid (GABA) activity, which contributes to its anxiolytic and stress-reducing effects. For vascular health, Gotu Kola strengthens blood vessel walls by stimulating the production of type I collagen in the vascular wall and improving microcirculation. It enhances venous tone and decreases capillary permeability, which explains its efficacy in treating venous insufficiency and reducing edema.
The herb also inhibits platelet aggregation and improves blood flow through its mild vasodilatory effects. In wound healing and skin health, Gotu Kola’s triterpenoids stimulate fibroblast proliferation and increase collagen synthesis, particularly type I collagen, which is essential for wound repair and tissue regeneration. It enhances the tensile strength of newly formed skin and accelerates epithelialization. The herb also exhibits significant anti-inflammatory properties by inhibiting pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, and by suppressing the activity of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS).
This anti-inflammatory action is complemented by its ability to modulate the NF-κB signaling pathway, a key regulator of inflammatory responses. Gotu Kola’s antioxidant effects extend beyond the nervous system, as it scavenges free radicals throughout the body and reduces lipid peroxidation in various tissues. It also enhances cellular antioxidant capacity by increasing the levels of endogenous antioxidants like glutathione. At the molecular level, Gotu Kola influences several signaling pathways involved in cell proliferation, differentiation, and survival.
It modulates the mitogen-activated protein kinase (MAPK) pathway, which regulates cellular responses to various stimuli, and affects the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway, which plays a crucial role in cell survival and metabolism. Recent research suggests that Gotu Kola may also influence epigenetic mechanisms by modulating DNA methylation patterns and histone modifications, potentially explaining its long-term effects on gene expression and cellular function. Additionally, it has been shown to enhance mitochondrial function and biogenesis, improving cellular energy production and reducing oxidative stress generated by mitochondrial dysfunction. In the immune system, Gotu Kola exhibits immunomodulatory effects by balancing pro-inflammatory and anti-inflammatory responses, enhancing macrophage phagocytic activity, and modulating T-cell function.
This balanced approach to immune regulation contributes to its therapeutic potential in various inflammatory and immune-related conditions.
Optimal Dosage
Disclaimer: The following dosage information is for educational purposes only. Always consult with a healthcare provider before starting any supplement regimen, especially if you have pre-existing health conditions, are pregnant or nursing, or are taking medications.
Dosage of Gotu Kola varies based on the form used and the condition being treated. For standardized extracts (typically standardized to contain 40% asiaticoside, 29-30% asiatic acid, 29-30% madecassic acid, and 1-2% madecassoside), the typical dosage range is 60-180 mg daily, divided into 2-3 doses. For crude herb or dried leaf preparations, 500-1000 mg three times daily is commonly recommended.
By Condition
Condition | Dosage | Notes |
---|---|---|
Cognitive enhancement and neuroprotection | 300-600 mg of standardized extract (containing at least 40% total triterpenes) daily, divided into 2-3 doses | Effects may take 4-6 weeks to become noticeable; higher doses within this range may be more effective for age-related cognitive decline |
Anxiety and stress management | 500 mg of dried herb or 60-120 mg of standardized extract twice daily | May be combined with other anxiolytic herbs like Bacopa monnieri or Ashwagandha for enhanced effects |
Venous insufficiency and edema | 60-120 mg of standardized extract (TTFCA – Total Triterpenoid Fraction of Centella Asiatica) daily | Clinical studies have shown significant improvement in venous insufficiency symptoms after 2-4 weeks of consistent use |
Wound healing and scar prevention | Topical application of creams/ointments containing 1% Gotu Kola extract, applied 2-3 times daily; or 60-120 mg oral standardized extract daily | Combined topical and oral administration may provide enhanced benefits for severe wounds or scars |
Skin conditions (psoriasis, eczema) | Topical application of 0.5-1% extract twice daily; or 60-120 mg oral standardized extract daily | Consistent application for at least 4-8 weeks is recommended for noticeable improvement |
By Age Group
Age Group | Dosage | Notes |
---|---|---|
Adults (18-65 years) | 300-600 mg standardized extract or 500-1000 mg dried herb daily | Generally well-tolerated; start at lower doses and gradually increase as needed |
Elderly (65+ years) | 250-500 mg standardized extract daily, starting with lower doses | May be particularly beneficial for age-related cognitive decline and vascular issues; monitor for potential interactions with medications |
Children (under 18 years) | Not recommended without medical supervision | Limited safety data in pediatric populations; consult healthcare provider before use |
By Form
Form | Dosage | Notes |
---|---|---|
Standardized extract (40% asiaticoside) | 60-180 mg daily, divided into 2-3 doses | Most consistent potency and research support; preferred for therapeutic applications |
Dried herb/leaf powder | 500-1000 mg, 2-3 times daily | Contains the full spectrum of compounds but variable potency; may require higher doses for therapeutic effects |
Tincture (1:5 ratio) | 2-4 mL, 2-3 times daily | Rapid absorption; alcohol content may be a consideration for some individuals |
Tea | 1-2 teaspoons (2-4 g) of dried herb steeped in hot water for 10-15 minutes, consumed 2-3 times daily | Lower potency than extracts; pleasant way to consume but may require consistent, long-term use for therapeutic effects |
Topical preparations | Creams/ointments containing 0.5-1% extract, applied 2-3 times daily to affected areas | Particularly effective for wound healing, scar prevention, and skin conditions |
Timing Recommendations
For optimal absorption and effectiveness, Gotu Kola is best taken with meals to minimize potential gastrointestinal discomfort. When used for cognitive enhancement, morning and early afternoon dosing is recommended to potentially enhance daytime cognitive function without interfering with sleep. For anxiety and stress management, doses can be timed to coincide with periods of anticipated stress or taken regularly throughout the day for general anxiety reduction.
Cycling Recommendations
While there is no strong evidence suggesting tolerance development with Gotu Kola, some practitioners recommend cycling the herb (e.g., 8-12 weeks on, 2-4 weeks off) for long-term use to potentially enhance effectiveness and minimize any unforeseen adverse effects from continuous use. However, for conditions like venous insufficiency or wound healing, continuous use may be more appropriate until the desired therapeutic outcome is achieved.
Special Considerations
Standardized extracts are generally preferred for therapeutic applications due to their consistent potency and better research support. The triterpenoid content (asiaticoside, madecassoside, asiatic acid, and madecassic acid) is considered the primary marker for potency and efficacy.
When selecting a supplement, look for products standardized to contain at least 40% total triterpenes or 10% asiaticoside. For enhanced absorption, taking Gotu Kola with a small amount of healthy fat may be beneficial, as some of its active compounds are fat-soluble.
Bioavailability
Absorption Rate
The bioavailability of Gotu Kola’s active compounds varies significantly based on the specific triterpenoids and the formulation used. In general, the triterpene glycosides (asiaticoside and madecassoside) have relatively poor oral bioavailability (estimated at 20-30%) due to their large molecular size and hydrophilic nature, which limits passive diffusion across intestinal membranes. The free triterpene acids (asiatic acid and madecassic acid) show somewhat better absorption profiles (30-50% bioavailability) due to their more lipophilic nature.
Pharmacokinetics
Absorption: Absorption primarily occurs in the small intestine. The triterpene glycosides may undergo partial hydrolysis by intestinal beta-glucosidases to release their aglycones (asiatic acid and madecassic acid), which are then absorbed. Some absorption may also occur through active transport mechanisms.
Distribution: Once absorbed, the triterpenoids are distributed throughout the body, with evidence suggesting they can cross the blood-brain barrier, particularly the more lipophilic asiatic acid and madecassic acid. This explains their neurological and cognitive effects.
Metabolism: The triterpenoids undergo hepatic metabolism, primarily through phase I (oxidation, reduction, hydrolysis) and phase II (conjugation) reactions. Asiaticoside is metabolized to asiatic acid in the liver and intestine, while both asiatic acid and madecassic acid undergo glucuronidation and sulfation.
Elimination: The metabolites are primarily excreted through the kidneys in urine, with a smaller portion eliminated via biliary excretion in feces. The elimination half-life of the major triterpenoids ranges from 2.2-6.6 hours.
Onset Of Action: Acute effects may be noticed within 1-3 hours after ingestion, though many of the therapeutic benefits require consistent use over weeks to months.
Peak Plasma Concentration: Typically reached within 1.5-2.5 hours after oral administration for the free triterpene acids, and 2-4 hours for the glycosides.
Enhancement Methods
Method | Description | Effectiveness |
---|---|---|
Standardized extracts | Extracts standardized to contain higher concentrations of triterpenoids provide more consistent and potent effects compared to crude herb preparations. | Significantly improves therapeutic potential by ensuring consistent delivery of active compounds. |
Fat co-administration | Taking Gotu Kola with a meal containing healthy fats or oils may enhance the absorption of the more lipophilic compounds (asiatic acid and madecassic acid). | May increase bioavailability by 15-30% for the triterpene acids. |
Piperine co-administration | Black pepper extract (piperine) inhibits certain drug-metabolizing enzymes and P-glycoprotein efflux pumps, potentially enhancing the bioavailability of Gotu Kola’s active compounds. | Studies with similar herbal compounds suggest potential bioavailability enhancement of 30-50%, though specific data for Gotu Kola is limited. |
Water-soluble formulations | Newer formulations like Centell-S have been developed with enhanced water solubility compared to traditional extracts. | May significantly improve bioavailability, particularly of the glycosidic compounds, with some studies showing 2-3 fold increases in plasma concentrations. |
Liposomal delivery | Encapsulation of Gotu Kola extracts in phospholipid liposomes can enhance absorption by facilitating transport across intestinal membranes. | Emerging research suggests potential bioavailability improvements of 2-4 fold, though commercial liposomal Gotu Kola products are still limited. |
Micronization | Reducing particle size through micronization increases the surface area available for dissolution and absorption. | May improve dissolution rate and subsequent absorption by 20-40%, particularly for the less water-soluble compounds. |
Factors Affecting Absorption
Factor | Impact |
---|---|
Gastrointestinal pH | The slightly acidic environment of the stomach may enhance the solubility of certain triterpenoids, while the more alkaline intestinal environment may facilitate the absorption of others. Conditions that significantly alter GI pH may affect overall absorption. |
Food intake | Taking Gotu Kola with meals, particularly those containing fats, may enhance the absorption of lipophilic compounds but might slightly delay peak plasma concentrations. |
Intestinal microbiota | Gut bacteria may play a role in hydrolyzing the glycosides to their aglycones, potentially enhancing absorption. Variations in gut microbiota composition may contribute to individual differences in response. |
Age | Older adults may experience reduced absorption due to age-related changes in gastrointestinal function, potentially requiring adjusted dosing strategies. |
Concurrent medications | Drugs that alter gastric emptying, intestinal motility, or pH may affect the absorption of Gotu Kola’s active compounds. Additionally, medications that compete for the same metabolic enzymes may influence bioavailability. |
Timing Recommendations
For optimal absorption, Gotu Kola supplements are best taken with meals, particularly those containing some healthy fats. Dividing the daily dose into 2-3 administrations throughout the day may help maintain more consistent blood levels of the active compounds, given their relatively short half-lives. For cognitive enhancement, morning and early afternoon dosing is often recommended to align with daily cognitive demands.
Research Gaps
Despite its long history of use, detailed pharmacokinetic studies of Gotu Kola in humans are limited. More research is needed to fully characterize the absorption, distribution, metabolism, and excretion profiles of its various bioactive compounds, particularly in different populations and
when used in combination with other supplements or medications.
Additionally , the potential role of the gut microbiome in modulating the bioavailability of Gotu Kola’s active compounds warrants further investigation.
Safety Profile
Safety Rating
General Safety Assessment
Gotu Kola has a generally favorable safety profile when used at recommended dosages for short to medium-term periods (up to 6 months). It has been used traditionally for centuries with few reported serious adverse effects. Most clinical trials report good tolerability with mild, transient side effects. However, long-term safety data beyond 6-12 months is limited, and certain populations should exercise caution or avoid use.
Side Effects
Common:
Effect | Incidence | Management |
---|---|---|
Gastrointestinal discomfort | 5-15% of users | Taking with food may reduce symptoms; dividing daily dose into smaller, more frequent doses may help |
Nausea | 3-10% of users | Taking with food; starting with lower doses and gradually increasing |
Drowsiness | 2-8% of users | Adjusting timing of doses; avoiding concurrent use with other sedatives |
Headache | 2-5% of users | Usually transient; ensuring adequate hydration may help |
Uncommon:
Effect | Incidence | Management |
---|---|---|
Skin rash or itching | 1-3% of users | Discontinue use and consult healthcare provider; may indicate allergic reaction |
Dizziness | 1-3% of users | Taking while seated; avoiding sudden position changes; reducing dosage |
Dry mouth | 1-2% of users | Staying well-hydrated; using sugar-free lozenges or gum |
Rare:
Effect | Incidence | Management |
---|---|---|
Elevated liver enzymes | <1% of users | Discontinue use and seek medical evaluation; monitor liver function in those with pre-existing liver conditions |
Photosensitivity | <0.5% of users | Use sun protection; discontinue if severe reactions occur |
Allergic reactions (severe) | <0.1% of users | Seek immediate medical attention; discontinue use permanently |
Contraindications
Condition | Rationale |
---|---|
Pregnancy and breastfeeding | Insufficient safety data; some animal studies suggest potential effects on fetal development; traditionally considered contraindicated in pregnancy |
Pre-existing liver disease | Rare reports of hepatotoxicity; may potentially exacerbate existing liver conditions |
Scheduled surgery | May increase risk of sedation with anesthetics and potentially affect blood glucose levels; discontinue at least 2 weeks before scheduled surgery |
History of skin cancer or pre-cancerous skin lesions | Theoretical concern based on its effects on cell proliferation; insufficient evidence to establish safety |
Children under 12 years | Limited safety data in pediatric populations; benefits may not outweigh potential risks |
Drug Interactions
Drug Class | Examples | Interaction Type | Severity | Management |
---|---|---|---|---|
Sedatives and CNS depressants | Array | Additive sedation | Moderate | Avoid concurrent use or use with caution; monitor for excessive sedation |
Hepatotoxic medications | Array | Potential additive hepatotoxicity | Moderate to severe | Avoid concurrent use; monitor liver function if combination cannot be avoided |
Anticoagulants and antiplatelet drugs | Array | Potential increased bleeding risk | Moderate | Monitor for signs of bleeding; consider more frequent INR monitoring with warfarin |
Antidiabetic medications | Array | Potential additive hypoglycemic effects | Mild to moderate | Monitor blood glucose levels; dosage adjustments of diabetes medications may be necessary |
Diuretics | Array | Potential additive diuretic effect | Mild | Monitor for signs of dehydration or electrolyte imbalances |
Upper Limit
Most clinical studies have used doses up to 600 mg of standardized extract daily without significant adverse effects. Doses exceeding 1000 mg of standardized extract daily have not been well-studied and may increase the risk of side effects without providing additional benefits. For crude herb preparations, doses above 3000 mg daily are not recommended.
Long Term Safety
Safety data for continuous use beyond 6-12 months is limited. While no specific cumulative toxicity has been identified, periodic breaks from supplementation (e.g., 1-2 weeks off after every 3-4 months of use) may be prudent for those using Gotu Kola long-term. Regular monitoring of liver function is advisable for extended use.
Special Populations
Elderly: Generally well-tolerated, but start with lower doses (50-75% of standard adult dose) and monitor for increased sensitivity to sedative effects or interactions with medications commonly used in this population
Liver Impairment: Use with caution; start with reduced doses (50% of standard dose) and monitor liver function; avoid in severe liver disease
Kidney Impairment: Limited data; use with caution in moderate to severe renal impairment; consider reduced dosing
Autoimmune Conditions: Theoretical concern due to immunomodulatory effects; insufficient evidence to establish safety; use with caution and medical supervision
Allergic Potential
Gotu Kola belongs to the Apiaceae (Umbelliferae) family, which includes carrots, celery, and parsley. Individuals with known allergies to plants in this family may have an increased risk of allergic reactions to Gotu Kola and should exercise caution.
Toxicology
Acute Toxicity: Animal studies show low acute toxicity with LD50 values >2000 mg/kg body weight for extracts
Subchronic Toxicity: 90-day studies in rodents show no significant adverse effects at doses equivalent to 5-10 times the human therapeutic dose
Genotoxicity: Standard genotoxicity assays (Ames test, chromosomal aberration) have generally been negative at therapeutic concentrations
Carcinogenicity: Limited long-term studies; no evidence of carcinogenic potential in available research, but comprehensive carcinogenicity testing is lacking
Reproductive Toxicity: Some animal studies suggest potential effects on fetal development; avoid during pregnancy until more safety data is available
Overdose Information
Limited reports of significant overdose exist. Theoretical symptoms might include severe gastrointestinal distress, excessive sedation, dizziness, confusion, and potentially liver stress. Treatment would be supportive, including gastric decontamination if recently ingested, and monitoring of liver function. No specific antidote is known.
Safety Monitoring Recommendations
For long-term use (>3 months), periodic monitoring of liver function (every 3-6 months) is advisable. Those with pre-existing medical conditions or taking multiple medications should consult healthcare providers before use and undergo appropriate monitoring based on individual risk factors.
Regulatory Status
Fda Status
Classification: Dietary Supplement
Approval Status: Not FDA-approved as a drug
Regulatory Framework: Regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994
Marketing Restrictions: Cannot be marketed with claims to treat, cure, or prevent any disease
Gras Status: Not generally recognized as safe (GRAS) for use in conventional foods
Safety Notifications: No significant FDA safety alerts or mandatory recalls specifically for Gotu Kola as of 2024
Notes: While available as a supplement, manufacturers are responsible for ensuring safety before marketing; FDA can take action against unsafe products after they reach the market
International Status
Eu
- Approved in Commission E Monographs for wound healing and venous insufficiency
- Registered medicinal products available for venous conditions
- Available both as registered medicine and food supplement
- Available primarily as food supplement; some traditional herbal registrations
Canada
- Natural Health Product (NHP)
- Regulated under the Natural Health Products Regulations
- Several licensed products with Natural Product Numbers (NPNs)
- Licensed products may claim to help support peripheral circulation and wound healing when specific quality and safety requirements are met
- Health Canada has published a monograph for Gotu Kola providing guidance on acceptable claims, dosage, and safety information
Australia
- Listed medicine on the Australian Register of Therapeutic Goods (ARTG)
- Regulated by the Therapeutic Goods Administration (TGA)
- May be marketed with low-level claims related to traditional use in herbal medicine
- Must comply with quality and safety standards; evidence for efficacy based on traditional use is acceptable for listed medicines
India
- Ayurvedic medicine; also available as food supplement
- Regulated under the Drugs and Cosmetics Act, 1940 and Rules 1945 as amended for Ayurvedic medicines
- Recognized in official Ayurvedic pharmacopoeias and formularies
- Widely used in traditional medicine with extensive historical documentation supporting its use
China
- Traditional Chinese Medicine (TCM)
- Regulated by the National Medical Products Administration (NMPA)
- Listed in the Chinese Pharmacopoeia
- Long history of documented use in TCM; subject to quality control standards specified in the pharmacopoeia
Japan
- Non-prescription quasi-drug or dietary supplement depending on formulation and claims
- Regulated by the Ministry of Health, Labour and Welfare
- Stricter regulation than many countries for health claims on supplements
Clinical Guidelines
Inclusion In Treatment Protocols
- Some European clinical guidelines mention standardized Centella asiatica extracts as an option for chronic venous insufficiency
- Limited inclusion in wound care protocols, primarily in integrative medicine settings
- Not typically included in mainstream clinical guidelines for cognitive conditions, though mentioned in some integrative medicine protocols
Professional Organization Positions
- Recognized as safe when used appropriately; included in Botanical Safety Handbook
- Monograph supports use for venous insufficiency and wound healing
- Included in WHO monographs on selected medicinal plants
Import Regulations
Personal Use: Generally permitted for personal use in most countries in limited quantities (typically 1-3 months supply)
Commercial Import: Subject to dietary supplement or herbal medicine import regulations depending on the country
Customs Considerations: May be subject to inspection; documentation of identity and purity may be required for larger quantities
Quality Standards
Pharmacopoeial Monographs
- No official monograph, but quality standards available through USP Dietary Supplement Verification Program
- Official monograph establishing quality standards for medicinal use
- Detailed monograph with quality specifications
- Official monograph with quality standards for TCM use
Industry Standards
- Detailed monograph with botanical identification, analytical methods, and quality control parameters
- Methods for analysis of triterpenoid content
Legal Status For Sports
Wada Status: Not on the World Anti-Doping Agency Prohibited List
Testing: Not typically included in standard anti-doping screening protocols
Sports Organization Policies: No major sports organizations specifically prohibit Gotu Kola use
Notes: Athletes should exercise caution with all supplements due to potential contamination risks
Future Regulatory Trends
Potential Changes: Increasing standardization of quality requirements globally; potential for more specific health claims in some jurisdictions based on growing clinical evidence
Research Impact: Ongoing clinical research may support expanded approved indications in countries with traditional herbal medicine registration pathways
Harmonization Efforts: International initiatives to harmonize herbal medicine regulations may affect Gotu Kola’s regulatory status across borders
Labeling Requirements
Usa: Must be labeled as dietary supplement; cannot make disease claims; structure/function claims must be accompanied by FDA disclaimer
Eu: When sold as food supplement, must comply with Food Supplements Directive labeling requirements; as THMP, requires approved product information
Canada: Must display Natural Product Number (NPN), medicinal and non-medicinal ingredients, recommended use, cautions, and warnings
Common Warnings: Pregnancy/breastfeeding warning; potential medication interaction warning; discontinue before surgery warning
Synergistic Compounds
Antagonistic Compounds
Cost Efficiency
Relative Cost
Low to Medium
Cost Per Effective Dose
Daily Cost Range: $0.10 – $1.50 for typical effective dose (300-600 mg standardized extract or 500-1000 mg dried herb)
Monthly Cost Range: $3 – $45 for continuous use
Annual Cost Range: $36 – $540 for continuous use
Notes: Costs vary significantly based on form, standardization level, brand reputation, and purchase volume. Bulk herbs and non-standardized preparations are typically at the lower end of the range, while highly standardized extracts and premium brands are at the higher end.
Price Comparison By Form
Form | Typical Price Range | Cost Per Effective Dose | Notes |
---|---|---|---|
Dried herb (bulk) | $15 – $30 per pound (454 g) | $0.10 – $0.20 for 3-6 g daily dose | Most economical option but requires preparation (tea) or encapsulation; potency and quality can be highly variable |
Powdered herb (capsules) | $8 – $20 for 60-100 capsules (500 mg each) | $0.25 – $0.65 for 1000 mg daily dose | Convenient but still variable in potency; moderate cost option |
Standardized extract (capsules) | $15 – $35 for 60 capsules (300-500 mg each) | $0.50 – $1.20 for 300-600 mg daily dose | Higher cost but more consistent potency and potentially greater efficacy; preferred for therapeutic applications |
Tincture (1:5 ratio) | $12 – $25 for 1-2 oz (30-60 ml) | $0.40 – $0.85 for 2-4 ml daily dose | Moderate cost; convenient liquid form with relatively rapid absorption; alcohol content may be a consideration |
Premium formulations | $25 – $60 for 30-60 servings | $0.85 – $2.00 daily | Includes liposomal formulations, water-soluble extracts, and combination products; highest cost but may offer enhanced bioavailability |
Value Analysis
Cost Effectiveness Rating: 4 out of 5
Cost Vs Benefit Assessment: Gotu Kola offers good to excellent value for its cognitive enhancement, wound healing, and vascular health benefits. The relatively low cost, especially for basic forms, combined with its well-established safety profile and moderate to strong evidence for several applications, makes it one of the more cost-effective herbal supplements available. For cognitive enhancement, the cost-to-benefit ratio is particularly favorable compared to many synthetic nootropics or premium herbal formulations.
Comparison To Alternatives: For Venous Insufficiency: Significantly less expensive than prescription medications like pentoxifylline or micronized purified flavonoid fraction, with comparable efficacy for mild to moderate cases, For Cognitive Enhancement: Much less expensive than prescription cognitive enhancers, though direct comparative efficacy studies are limited, For Wound Healing: Comparable or lower cost than many advanced wound care products, particularly for minor wounds and prevention of excessive scarring, Vs Ginkgo Biloba: Similar or slightly lower cost for cognitive enhancement, with complementary but different mechanisms of action, Vs Bacopa Monnieri: Comparable cost for cognitive enhancement; Bacopa has more human clinical trials for memory specifically, while Gotu Kola has broader applications, Vs Horse Chestnut: Similar cost range for venous conditions; often used complementarily
Cost Saving Strategies: Purchasing bulk dried herb for tea preparation offers the lowest cost per dose, though standardization and convenience are sacrificed, Buying larger quantities of standardized extracts (e.g., 120-count bottles vs. 60-count) typically reduces cost per dose by 15-30%, Subscription services through online retailers often provide 10-15% discounts for regular purchases, Growing your own Gotu Kola is possible in suitable climates (USDA zones 9-11) and can significantly reduce costs for long-term users
Market Trends
Price Stability: Relatively stable pricing over the past decade with modest inflation-related increases; occasional fluctuations due to harvest conditions in major producing regions
Availability Trends: Increasing availability in Western markets as interest in traditional Ayurvedic and TCM herbs grows
Market Competition: Growing number of manufacturers has helped maintain competitive pricing, particularly for basic forms
Premium Segment Growth: Emerging market for enhanced delivery systems (liposomal, water-soluble) commanding premium prices, targeting the cognitive enhancement and anti-aging markets
Insurance Coverage
Conventional Insurance: Generally not covered by conventional health insurance in most countries
Flexible Spending Accounts: May be eligible for FSA/HSA reimbursement in the US if prescribed by a healthcare provider for a specific medical condition
Integrative Medicine Plans: Some specialized integrative medicine insurance plans or health sharing programs may provide partial coverage
Exceptions: In Germany and some European countries, physician-prescribed herbal medicines may receive partial reimbursement for approved indications
Cost Per Bioactive Compound
Triterpenoid Content: When comparing products, cost per mg of total triterpenoids or specific markers (asiaticoside, madecassoside) provides a more accurate value assessment than simply cost per gram of product
Standardized Extract Value: A 300 mg capsule of extract standardized to 40% triterpenoids provides 120 mg of active compounds, while a 500 mg capsule of raw herb at 2% natural triterpenoid content provides only 10 mg
Calculation Example: For a product costing $20 for 60 capsules of 300 mg standardized to 40% triterpenoids: Cost per mg of triterpenoids = $20 ÷ (60 × 300 mg × 0.40) = $0.0028 per mg of triterpenoids
Long Term Economic Considerations
Preventive Value: Potential cost savings from preventive use for cognitive maintenance and vascular health, though difficult to quantify precisely
Sustainability Concerns: Growing commercial demand has raised concerns about wild harvesting sustainability, which may impact future pricing if cultivation doesn’t keep pace
Research Impact: Ongoing clinical research may increase demand and potentially affect pricing, particularly if new applications receive stronger scientific validation
Stability Information
Shelf Life
Dried Herb: 1-2 years when properly stored in airtight containers away from light, heat, and moisture
Powdered Herb: 6-12 months; more susceptible to oxidation and degradation due to increased surface area
Standardized Extracts: 2-3 years for capsules and tablets; stability enhanced by standardization process and protective packaging
Tinctures: 3-5 years; alcohol content provides preservative effect and extends shelf life
Topical Preparations: 1-2 years unopened; 6-12 months after opening, depending on preservative system and packaging
Storage Recommendations
Temperature: Store between 15-25°C (59-77°F). Avoid temperature extremes; high temperatures accelerate degradation of triterpenoids, while freezing may affect physical stability of liquid preparations.
Humidity: Maintain low humidity environment (<60% relative humidity). Gotu Kola and its extracts can absorb moisture, leading to degradation of active compounds and potential microbial growth.
Light Exposure: Protect from light, especially UV light, which can catalyze oxidation of active compounds. Store in opaque or amber containers.
Air Exposure: Minimize exposure to oxygen, which can oxidize triterpenoids and other active compounds. Use airtight containers and consider oxygen absorbers for bulk storage.
Container Recommendations: Glass or high-density polyethylene (HDPE) containers are preferred for long-term storage. Avoid polyvinyl chloride (PVC) containers, which may interact with plant compounds.
Degradation Factors
Factor | Impact | Indicators | Prevention |
---|---|---|---|
Oxidation | Primary degradation pathway for triterpenoids, particularly asiatic acid and madecassic acid; results in loss of therapeutic activity | Darkening of color, development of rancid odor, reduced potency in analytical testing | Antioxidant additives in commercial preparations; nitrogen flushing of packages; airtight containers; oxygen absorbers for bulk storage |
Hydrolysis | Affects glycosidic bonds in asiaticoside and madecassoside, converting them to their respective aglycones; may alter bioavailability and efficacy | Changes in chromatographic profile; shift in ratio of glycosides to aglycones | Control of moisture; desiccants in packaging; proper drying before storage |
Microbial contamination | Can lead to degradation of active compounds, production of toxic metabolites, and safety concerns | Visible mold growth, unusual odor, elevated microbial counts in testing | Proper drying (moisture content <10%); preservatives in liquid preparations; good manufacturing practices during processing |
Enzymatic degradation | Plant enzymes can remain active in improperly processed material, leading to degradation of active compounds | Rapid loss of potency in freshly dried material; changes in sensory characteristics | Heat treatment during processing to inactivate enzymes; proper drying techniques |
pH extremes | Can accelerate hydrolysis of glycosides and degradation of triterpenoids | Particularly relevant for liquid preparations; may show precipitation or color changes | pH buffering in liquid formulations; proper formulation design |
Stability Testing Methods
Method | Description | Parameters Monitored | Typical Protocol |
---|---|---|---|
Accelerated stability testing | Storage under elevated temperature and humidity conditions (typically 40°C/75% RH) to predict long-term stability | Triterpenoid content, microbial limits, physical appearance, moisture content | Testing at 0, 1, 3, and 6 months under accelerated conditions to predict 2-year shelf life under normal conditions |
Real-time stability testing | Storage under recommended conditions with periodic testing to confirm shelf life estimates | Same as accelerated testing, but under actual recommended storage conditions | Testing at 0, 3, 6, 12, 18, and 24 months for a 2-year shelf life claim |
Photostability testing | Exposure to defined light conditions to assess light sensitivity | Changes in triterpenoid content, color, and other physical characteristics | |
Freeze-thaw cycle testing | Subjecting product to repeated freezing and thawing to assess physical stability | Physical appearance, homogeneity, active compound content |
Degradation Products
Primary Degradation Compounds: Oxidation products of asiatic acid and madecassic acid; hydrolysis products of asiaticoside and madecassoside
Safety Implications: Most degradation products have not been associated with significant toxicity, but may result in reduced efficacy
Detection Methods: HPLC with UV or mass spectrometric detection can identify and quantify both parent compounds and degradation products
Formulation Stability Factors
Excipients: Certain excipients can enhance stability, particularly antioxidants (e.g., vitamin E, rosemary extract) for protection against oxidation
Processing Techniques: Microencapsulation, coating, or liposomal formulation can enhance stability by protecting active compounds from environmental factors
Packaging Considerations: Blister packs provide better protection than bottles for solid dosage forms; airless pumps better than jars for creams and gels
Stability Differences By Compound
Asiaticoside And Madecassoside: Generally more stable to oxidation than their aglycones but more susceptible to hydrolysis
Asiatic Acid And Madecassic Acid: More susceptible to oxidation but resistant to hydrolysis; often the first compounds to show degradation in stability testing
Flavonoids And Phenolics: Secondary compounds that contribute to antioxidant activity; generally less stable than triterpenoids and may degrade more rapidly
Reconstitution Guidelines
Dried Extracts: If moisture has caused caking, gentle breaking apart in a dry environment may restore usability; significant clumping or color changes may indicate degradation
Liquid Preparations: If separation occurs, gentle shaking may restore homogeneity; precipitation or significant color changes may indicate degradation and the product should not be used
Travel Considerations
For travel, consider transferring only the needed amount to a small, airtight container rather than exposing the entire supply to variable conditions. Solid dosage forms (tablets, capsules) maintain better stability during travel than liquids or powders. Avoid leaving supplements in hot vehicles or checked luggage that may experience temperature extremes.
Sourcing
Natural Sources
Source | Description | Active Compound Concentration | Sustainability Concerns |
---|---|---|---|
Centella asiatica plant | Gotu Kola is derived from the Centella asiatica plant, a small herbaceous annual plant native to wetland areas of Asia, particularly India, Sri Lanka, China, Indonesia, and Malaysia. It has also naturalized in parts of Africa, Australia, and the Americas. | Wild-harvested plants typically contain 1-8% total triterpenoids, with concentration varying based on growing conditions, harvest time, and plant part used. | Increasing commercial demand has led to overharvesting in some regions, raising sustainability concerns. Cultivation is becoming more common to meet demand while preserving wild populations. |
Cultivation Methods
Traditional field cultivation
Controlled environment cultivation
Organic cultivation
Tissue culture propagation
Processing Methods
Traditional air drying
Controlled temperature drying
Extraction and standardization
Advanced formulation technologies
Quality Considerations
- Macroscopic and microscopic examination of plant material to confirm correct species
- DNA barcoding for definitive species identification, particularly important to distinguish from potential adulterants
- Thin-layer chromatography (TLC) fingerprinting to verify characteristic compound profile
- High-Performance Liquid Chromatography (HPLC) for quantification of key triterpenoids (asiaticoside, madecassoside, asiatic acid, madecassic acid)
- Mass spectrometry for detailed compound identification and quantification
- Spectrophotometric methods for total triterpenoid content
- Heavy metal testing (lead, arsenic, cadmium, mercury) – particularly important as Gotu Kola can accumulate heavy metals from soil
- Pesticide residue screening – especially relevant for non-organic sources
- Microbial testing for pathogenic organisms, yeast, and mold
- Mycotoxin screening, particularly aflatoxins and ochratoxin A
- Triterpenoid content: Higher-quality products typically contain at least 40% total triterpenoids or 10% asiaticoside
- Appearance: Properly dried material should maintain a green color; browning indicates poor processing or storage
- Aroma: Fresh, slightly sweet aroma; musty smell may indicate improper drying or storage
- Moisture content: Should be below 10% to prevent microbial growth and degradation
Commercial Forms
Dried herb
Powdered herb
Standardized extracts
Tinctures
Topical preparations
Enhanced delivery systems
Reputable Suppliers
Category | Examples | Quality Indicators |
---|---|---|
Raw material suppliers |
|
GMP certification, standardized extracts, third-party testing, detailed certificates of analysis, sustainable sourcing practices |
Consumer supplement brands |
|
Standardized extracts, transparent sourcing, third-party testing, clear labeling of active compound content |
Storage Recommendations
- Store in airtight containers away from light, heat, and moisture; shelf life approximately 1-2 years when properly stored.
- More susceptible to oxidation; store in airtight, opaque containers; shelf life approximately 6-12 months.
- Generally more stable than raw herb; store according to manufacturer recommendations; typically 2-3 years shelf life for standardized extracts.
- Store in dark glass bottles away from heat; shelf life approximately 3-5 years due to preservative effect of alcohol.
- Cool, dry place away from direct sunlight; refrigeration not necessary but may extend shelf life, particularly for liquid preparations after opening.
Historical Usage
Gotu Kola (Centella asiatica) has a rich and extensive history of traditional use spanning thousands of years across multiple medical systems, particularly in Asia. In Ayurvedic medicine, where it is known as ‘Brahmi’ or ‘Mandukaparni,’ Gotu Kola has been used for at least 3,000 years and is mentioned in ancient texts including the Sushruta Samhita (circa 6th century BCE). Ayurvedic practitioners classified it as a ‘medhya rasayana,’ an herb that enhances memory and longevity, and used it to treat a wide range of conditions including skin disorders, nervous system ailments, and to promote mental clarity and spiritual development. It was considered one of the primary herbs for balancing the pitta dosha (fire element) and was believed to enhance all three doshas (vata, pitta, and kapha).
In Traditional Chinese Medicine (TCM), where it is known as ‘Ji Xue Cao’ (literally ‘gathering blood herb’), Gotu Kola has been used for over 2,000 years. Chinese physicians primarily employed it to clear heat, promote diuresis, detoxify the body, and heal wounds. It was particularly valued for treating fevers, urinary tract infections, and skin conditions including leprosy. TCM practitioners also recognized its cooling properties and used it to balance excess heat in the liver and to promote longevity.
In traditional Indonesian medicine, Gotu Kola (known locally as ‘Pegagan’) has been used for centuries to enhance memory, treat fever, improve circulation, and heal wounds. Indonesian mothers traditionally gave Gotu Kola to children to enhance their intelligence and mental development. In Sri Lankan traditional medicine (Sinhala medicine), the herb (known as ‘Gotukola’) has been a staple in the diet and medical system for generations, used both as a medicinal herb and a common leafy vegetable. Sri Lankan practitioners used it to purify blood, promote wound healing, and improve mental function.
Throughout Southeast Asia, Gotu Kola gained a reputation as a longevity herb, with legends of ancient sages living for extraordinary lengths of time by consuming it regularly. This led to its nickname ‘the herb of longevity’ or ‘fountain of youth.’ The herb’s association with the elephant’s memory and longevity (elephants are known to eat the plant in the wild) further cemented its reputation for enhancing cognitive function and extending lifespan. In folk medicine across various cultures, Gotu Kola was commonly applied topically as a poultice for wounds, burns, and skin conditions. It was also prepared as teas, decoctions, and fresh juices for internal use.
Traditional preparation methods varied by region but often involved either consuming the fresh leaves, creating dried powders, or extracting the herb in water, milk, ghee (clarified butter), or alcohol. The introduction of Gotu Kola to Western medicine began in the early 20th century when European researchers began investigating its wound-healing properties. French scientists in the 1930s and 1940s conducted some of the first modern research on the herb, particularly for treating leprosy and skin conditions. By the mid-20th century, standardized extracts of Centella asiatica, particularly the total triterpenoid fraction (TTFCA), began to be used in European clinical settings for wound healing and vascular conditions.
The herb gained significant attention in Western herbal medicine during the 1960s and 1970s as interest in traditional medical systems increased. Modern scientific research began to validate many of its traditional uses, particularly for wound healing, venous insufficiency, and cognitive enhancement. Today, Gotu Kola continues to be used in its traditional contexts while also being incorporated into modern integrative medicine practices worldwide. It has transitioned from primarily traditional use to becoming a well-researched herbal medicine with applications supported by both centuries of empirical observation and modern scientific investigation.
The herb represents a fascinating example of traditional wisdom that has withstood the test of time and continues to find relevance in contemporary healthcare approaches.
Scientific Evidence
Evidence Rating
Evidence Summary
Gotu Kola (Centella asiatica) has a moderate to strong body of scientific evidence supporting several of its traditional uses, particularly for wound healing, venous insufficiency, and cognitive function. The research includes numerous in vitro and animal studies, as well as a growing number of human clinical trials, though many are of moderate quality or have methodological limitations. The strongest evidence exists for its wound healing and venous applications, with emerging but promising evidence for its cognitive and neuroprotective effects.
The active triterpenoid compounds have been well-characterized, and their mechanisms of action are increasingly understood at the molecular level.
Key Studies
Meta Analyses
Ongoing Trials
Research Gaps
Long-term safety and efficacy studies (>12 months) are lacking, Limited research on potential interactions with commonly prescribed medications, Insufficient standardization across studies regarding extract composition and dosing, Need for larger, well-designed clinical trials in diverse populations, Limited research on comparative efficacy versus conventional treatments for specific conditions, Incomplete understanding of the relative contributions of individual compounds to the overall therapeutic effects
Expert Consensus
There is growing consensus among researchers and clinicians that Gotu Kola has legitimate therapeutic potential, particularly for cognitive enhancement, wound healing, and venous conditions. The herb is generally recognized as safe
when used appropriately, though experts emphasize the importance of using standardized extracts for therapeutic purposes.
While traditional uses span a wide range of conditions, experts typically focus on the applications with stronger scientific support.
There is particular interest in its potential as a neuroprotective agent for age-related cognitive decline and neurodegenerative conditions, though most experts agree that larger clinical trials are needed before making definitive recommendations for
these applications.
Historical Research Trends
Research on Gotu Kola has evolved significantly over the past several decades. Early studies (1970s-1990s) focused primarily on its wound healing and dermatological applications, with particular attention to its effects on collagen synthesis and fibroblast proliferation. The late 1990s and early 2000s saw increased interest in its vascular effects, particularly for chronic venous insufficiency and microangiopathy. Since the 2010s, there has been a notable shift toward investigating its neurological and cognitive effects, reflecting growing interest in natural approaches to cognitive enhancement and neuroprotection.
Recent research has increasingly focused on elucidating molecular mechanisms and identifying specific active compounds responsible for various therapeutic effects, with particular attention to the triterpenoid constituents.
Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a healthcare professional before starting any supplement regimen, especially if you have pre-existing health conditions or are taking medications.